Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 37, Pages 4834-4844
Publisher
Springer Nature
Online
2014-12-08
DOI
10.1038/onc.2014.402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures
- (2014) S. Matsumoto et al. EMBO JOURNAL
- Wnt5a signaling promotes apical and basolateral polarization of single epithelial cells
- (2013) Hidetoshi Gon et al. MOLECULAR BIOLOGY OF THE CELL
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo
- (2013) Yoshinori Kagawa et al. PLoS One
- Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
- (2013) M. A. Nieto SCIENCE
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
- (2012) Hsing-Chen Tsai et al. CANCER CELL
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Restriction of intestinal stem cell expansion and the regenerative response by YAP
- (2012) Evan R. Barry et al. NATURE
- Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
- (2011) N. Sunaga et al. MOLECULAR CANCER THERAPEUTICS
- An Anti-Wnt5a Antibody Suppresses Metastasis of Gastric Cancer Cells In Vivo by Inhibiting Receptor-Mediated Endocytosis
- (2011) H. Hanaki et al. MOLECULAR CANCER THERAPEUTICS
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
- (2010) Qing-Bai She et al. CANCER CELL
- Traf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth
- (2010) Miki Shitashige et al. CANCER RESEARCH
- Binding of APC and dishevelled mediates Wnt5a-regulated focal adhesion dynamics in migrating cells
- (2010) Shinji Matsumoto et al. EMBO JOURNAL
- Comprehensive methylome map of lineage commitment from haematopoietic progenitors
- (2010) Hong Ji et al. NATURE
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- ADP-ribosylation factor like 7 (ARL7) interacts with α-tubulin and modulates intracellular vesicular transport
- (2009) Shu-mei Wei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Wnt5a regulates distinct signalling pathways by binding to Frizzled2
- (2009) Akira Sato et al. EMBO JOURNAL
- Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
- (2009) Hideki Yamamoto et al. GASTROENTEROLOGY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
- (2009) Baozhi Chen et al. Nature Chemical Biology
- Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung
- (2008) Jun-ichiro Ikeda et al. CANCER SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started